Clinical Trials | April 16, 2024
Novartis reports data from trial of IgA nephropathy treatment
IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide
IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
Hepatitis B infects over 40 million people in India
Pharma Solutions operates 10 research and development and/or production sites globally
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
Women emerge as the cornerstone of this monumental undertaking
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
The fast pace of construction of AIIMS Jammu whose foundation stone laying to inauguration took only 5 years highlights the commitment of the Government
AIIMS Rewari is a 750-bed hospital complex which includes a 100 seat medical college, a 60 seat nursing college, a 30-bed AYUSH block
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
Subscribe To Our Newsletter & Stay Updated
